MSME Pharma Firms Seek Financial and Regulatory Support for GMP Compliance Amid NSQ Concerns

MSME pharma firms have asked for Rs 50 crore handholding and an extension for GMP compliance under revised Schedule M. Only 1,600 units out of 8,500 have submitted a gap analysis plan to the CDSCO. The Drug Controller General of India expressed disappointment with pharma manufacturing associations and urged them to ensure member units uphold quality norms.